Clinical Trial Update: A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and tolerability of Pancrelipase Microtablet Capsules for exocrine pancreatic insufficiency in cystic fibrosis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Malabsorption Syndromes

Drugs mentioned

• Pancrelipase Microtablet Capsules (pancrelipase)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Exocrine Pancreatic Insufficiency, Steatorrhea | Phase 3 | Status: COMPLETED | Results posted: 2010-03-17